Explaining Non-Pharmac medicines coverage
Non-Pharmac medicines coverage – aiming for a data-informed evaluation
Non-Pharmac coverage has become increasingly important to clients purchasing private health insurance, primarily due to rising public demand for treatments and medications not funded by Pharmac (the government agency overseeing public pharmaceutical purchasing and subsidy).
Recent coverage focused on the severity of a serious illness and whether it can be cured as a potential limitation to non-Pharmac coverage. We felt it was worth clarifying that, in effect every policy with a non-Pharmac benefit includes some limitations of this nature – though they may appear in different places and be expressed in different ways within the policy wording.
Click the button below to subscribe and will have free unlimited access for a limited time to full article and all other articles on the site.
You will also be able to comment on articles on Good Returns.
